Articles dans des revues avec comité de lecture (192)
  1. 148. Demanet, C., Brissinck, J., Moser, M., Leo, O., & Thielemans, K. (1992). Bispecific antibody therapy of two murine B-cell lymphomas. International journal of cancer. Supplement, 7, 67-68.
  2. 149. De Wit, D., Van Mechelen, M., Ryelandt, M., Figueiredo, A., Abramowicz, D., Goldman, M., Bazin, H., Urbain, J., & Leo, O. (1992). The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. The Journal of experimental medicine, 175(1), 9-14.
  3. 150. Deblandre, G., Leo, O., Huez, G., & Wathelet, M. (1992). CD69 is expressed on Daudi cells in response to interferon-alpha. Cytokine, 4(1), 36-43.
  4. 151. Sornasse, T., Flamand, V., De Becker, G., Bazin, H., Tielemans, F., Thielemans, K., Urbain, J., Leo, O., & Moser, M. (1992). Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. The Journal of experimental medicine, 175(1), 15-21.
  5. 152. Brissink, J., Demanet, C., Leo, O., & Thielemans, K. M. (1992). Bispecific antibody therapy. Drugs of the future, 17, 1003-1010.
  6. 153. Brissinck, J., Demanet, C., Moser, M., Leo, O., & Thielemans, K. (1991). Treatment of mice bearing BCL1 lymphoma with bispecific antibodies. The Journal of immunology, 147(11), 4019-4026.
  7. 154. Alegre, M.-L., Gastaldello, K., Abramowicz, D., Kinnaert, P., Vereerstraeten, P., De Pauw, L., Vandenabeele, P., Moser, M., Leo, O., & Goldman, M. (1991). Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation, 52(4), 674-679.
  8. 155. Demanet, C., Brissinck, J., Van Mechelen, M., Leo, O., & Thielemans, K. (1991). Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3). The Journal of immunology, 147(3), 1091-1097.
  9. 156. Andris, F., Van Mechelen, M., Legrand, N., Dubois, P., Kaufman, M., Urbain, J., & Leo, O. (1991). Induction of long-term but reversible unresponsiveness after activation of murine T cell hybridomas. International immunology, 3(6), 609-616. doi:10.1093/intimm/3.6.609
  10. 157. Wissing, K. M., Marchant, A., Moser, M., Flamand, V., Leo, O., Abramowicz, D., Urbain, J., & Goldman, M. (1991). Modulation of murine host-versus-graft disease by anti-CD3 monoclonal antibody. Clinical and experimental immunology, 83(2), 333-337. doi:10.1111/j.1365-2249.1991.tb05638.x
  11. 158. Alegre, M.-L., Vandenabeele, P., Depierreux, M., Florquin, F., Deschodt Lanckman, M., Flamand, V., Moser, M., Leo, O., Urbain, J., Fiers, W., & Goldman, M. (1991). Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice. The Journal of immunology, 146, 1184-1991.
  12. 159. Doutrelepont, J.-M., Moser, M., Leo, O., Abramowicz, D., Vanderhaegen, M. L., Urbain, J., & Goldman, M. (1991). Hyper IgE in stimulatory graft-versus-host disease: role of interleukin-4. Clinical and experimental immunology, 83(1), 133-136. doi:10.1111/j.1365-2249.1991.tb05602.x
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>